IL17A and systemic lupus erythematosus: ICT’s effect on IL-17 suggests it may have a far-reaching effect on lupus immunomodulation because IL-17 is upregulated in SCLE patients and increases inflammatory cytokines and chemokines, neutrophil recruitment, stimulates T cells, and increases the production of autoantibodies (Méndez-Flores et al., 2016).